RUTH HART: Open Payments
NPI 1336729888 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,181 in 74 payments from 13 companies in 2025. Trend: 2023 $1,409 · 2024 $2,021 · 2025 $1,181
Food & beverage: $1,181
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 20 | $231 |
| ABBVIE INC. | 15 | $166 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $147 |
| Neurocrine BioSciences, Inc. | 6 | $135 |
| Axsome Therapeutics, Inc. | 5 | $109 |
| Alkermes, Inc. | 4 | $73 |
| Corium, LLC | 4 | $69 |
| Teva Pharmaceuticals USA, Inc. | 4 | $59 |
| Lundbeck LLC | 3 | $51 |
| Vanda Pharmaceuticals Inc. | 3 | $46 |
Products named: REXULTI, VRAYLAR, CAPLYTA, INGREZZA, Auvelity, ARISTADA, Azstarys, AUSTEDO XR.
Industry payments across KS — which companies pay providers there.
